Medtronic Diabetes Business MiniMed Seeks $784 Million in US IPO

Medtronic Diabetes Business MiniMed Seeks $784 Million in US IPO

MiniMed Group Inc., a diabetes management firm that will be separated from health-care giant Medtronic Plc, is seeking to raise as much as $784 million in an initial public offering.

📰 Original Source

Read full article at Bloomberg →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.